Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
ENVVENO MED CORP

NVNO

$13.00Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$7M
MVM
+$0.0M
TD Variance
15.714

Every news event mapped to its market reaction — 66 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-08-20-76.2%legalSeeking AlphaenVVeno tanks after FDA rejects VenoValve approval
2025-08-20-76.2%legalSeeking AlphaenVVeno tanks after FDA rejects VenoValve approval (NVNO:NASDAQ) - Seeking Alpha
2025-08-20-76.2%legalInvesting.comenVVeno Medical stock plummets after FDA rejects VenoValve approval - Investing.com
2025-08-20-76.2%legalInvesting.comFDA rejects enVVeno Medical’s VenoValve for chronic venous insufficiency - Investing.com
2025-08-20-76.2%legalStock TitanFDA Rejects First-Ever Surgical Venous Valve Treatment: enVVeno's VenoValve Hits Regulatory Roadblock - Stock Titan
2025-11-14-43.0%legalInvesting.comenVVeno Medical stock plunges after FDA upholds rejection of VenoValve - Investing.com
2025-11-13-37.4%legalStock TitanenVVeno Medical (NASDAQ: NVNO): FDA upholds VenoValve PMA not-approvable on appeal - Stock Titan
2024-09-26-29.5%newsSeeking AlphaenVVeno Medical offers to sell common stock
2022-03-28+26.4%newsSeeking AlphaenVVeno Medical reports FY results
2024-09-27-25.6%legalSeeking AlphaenVVeno Medical stock falls after it prices $15M securities offering
2025-10-10-18.0%newsInvesting.comEnVVeno Medical receives Nasdaq notice for minimum bid price non-compliance - Investing.com
2025-05-01+16.1%earningsSeeking AlphaenVVeno Medical reports Q1 results
2021-09-08+12.3%legalSEC EDGARNVNO 8-K: 1.01 and (SEC Filing)
2024-03-06-10.1%newsSeeking AlphaenVVeno: The Road To Approval Seems Open From Here On
2024-03-06-10.1%newsSeeking AlphaenVVeno: The Road To Approval Seems Open From Here On (NASDAQ:NVNO) - Seeking Alpha
2022-08-03+9.8%earningsSeeking AlphaenVVeno Medical reports Q2 results
2025-12-12-9.6%newsInvesting.comEnVVeno Medical shareholders approve reverse stock split, reject equity plan - Investing.com
2023-03-03-7.1%earningsSeeking AlphaenVVeno Medical GAAP EPS of -$2.20 beats by $0.01
2026-02-04-6.9%newsACCESS NewswireenVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-02-04-6.9%legalSEC EDGARNVNO 8-K: 2.02, 8.01 (SEC Filing)
2021-08-12+6.5%legalSEC EDGARNVNO 8-K: 1.01 and (SEC Filing)
2021-10-01-6.4%newsStock TitanLatest NVNO News - enVVeno Medical Corporation Successfully Co... - Stock Titan
2026-03-03+6.0%newsGlobeNewswireNorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives
2021-11-11-5.6%earningsSeeking AlphaHancock Jaffe Laboratories reports Q3 results
2023-01-18+5.5%executiveSeeking AlphaenVVeno Medical promotes dr. Hamed Alavi to Senior Vice President and Chief Technology Officer
2026-01-15-5.5%newsSeeking AlphaenVVeno Medical announces reverse stock split; shares down 20%
2026-01-15-5.5%newsYahoo FinanceenVVeno Medical Announces Reverse Stock Split - Yahoo Finance
2026-01-15-5.5%newsStock TitanWhat enVVeno's 1-for-35 reverse stock split means for shareholders in 2026 - Stock Titan
2026-01-15-5.5%newsStock TitanLatest NVNO News - enVVeno Medical Reports Full Year 2025 Fina... - Stock Titan
2025-07-18-5.3%newssimplywall.stCompanies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth - simplywall.st
2022-09-23-5.2%newsSeeking AlphaenVVeno Medical: Unique Exposure To Venous Treatment Domain
2025-08-01+5.1%earningsSeeking AlphaenVVeno Medical reports Q2 results
2022-09-29+4.9%newsSeeking AlphaenVVeno Medical (NVNO) Investor Presentation - Slideshow
2025-05-19+4.4%executiveSeeking AlphaenVVeno Medical appoints Jennifer Bright as financial chief
2024-03-01+4.1%newsSeeking AlphaenVVeno Medical reports FY results
2024-02-29-4.0%newsSeeking AlphaenVVeno Medical reports FY results
2021-10-02-4.0%earningsMarketBeatenVVeno Medical (NVNO) Stock Price, News & Analysis - MarketBeat
2021-10-04-3.8%newsStockInvest.usEnvveno Medical Stock Price Forecast. Should You Buy NVNO? - StockInvest.us
2025-11-22+3.7%newssimplywall.stInsider Buyers Lose US$294k As enVVeno Medical Sheds US$1.9m - simplywall.st
2023-10-12+3.7%legalSEC EDGARNVNO 8-K: 1.01, 3.02 (SEC Filing)
2026-03-13-3.3%newsGuruFocusInsider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus
2025-05-20-2.7%legalSEC EDGARNVNO 8-K: 5.02 and (SEC Filing)
2024-05-09-2.7%earningsSeeking AlphaenVVeno Medical reports Q1 results
2025-03-03-2.4%earningsSeeking AlphaenVVeno Medical reports Q4 results
2021-10-08-2.4%newsTradingViewNVNO Stock Price and Chart — NASDAQ:NVNO - TradingView
2025-09-01+2.2%legalOrange County Business JournalenVVeno Medical Shares Plunge 79% on FDA Denial - Orange County Business Journal
2024-11-15-2.1%M&AGuruFocusPerceptive Advisors LLC's Strategic Acquisition in enVVeno Medical Corp - GuruFocus
2023-07-31+1.9%earningsSeeking AlphaenVVeno Medical reports Q2 results
2023-10-26-1.8%newsSeeking AlphaenVVeno Medical files to sell 14.71M shares for holders
2023-10-26-1.8%earningsSeeking AlphaenVVeno Medical reports Q3 results
2021-09-22-1.5%legalSEC EDGARNVNO 8-K: 8.01 and (SEC Filing)
2024-11-19+1.4%earningsSeeking AlphaenVVeno Medical rises on submission of the venovalve PMA application for FDA approval
2025-10-31+1.3%earningsSeeking AlphaenVVeno Medical reports Q3 results
2026-03-27-1.3%newsACCESS NewswireenVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
2026-03-27-1.3%earningsSeeking AlphaenVVeno Medical GAAP EPS of -$33.06
2026-03-27-1.3%newsACCESS NewswireenVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - ACCESS Newswire
2022-10-27-1.2%earningsSeeking AlphaenVVeno Medical reports Q3 results
2025-10-30-1.2%legalSEC EDGARNVNO 8-K: 1.01 and (SEC Filing)
2021-10-22+1.0%newsSeeking AlphaEnVVeno Medical announces 1st surgery in US trial using VenoValve for Venous Insufficiency
2024-08-01-0.8%earningsSeeking AlphaenVVeno Medical reports Q2 results
2024-09-30-0.7%legalSEC EDGARNVNO 8-K: 1.01 and (SEC Filing)
2025-04-25+0.7%newsStock TitanNVNO Stock Price, News & Analysis - Stock Titan
2025-03-13+0.7%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2023-05-01-0.4%earningsSeeking AlphaenVVeno Medical reports Q1 results
2026-03-26-0.1%newsStock Titan[10-K] enVVeno Medical Corp Files Annual Report | NVNO Annual Report (10-K) - Stock Titan
2022-05-02+0.0%earningsSeeking AlphaenVVeno Medical reports Q1 results
tickerdossier.comtickerdossier.substack.com